Mikkel Wandahl Pedersen

Keine laufenden Positionen mehr

50 Jahre

Health Technology

Consumer Services

Ehemalige bekannte Positionen von Mikkel Wandahl Pedersen

Unternehmen	Position	Beginn	Ende
NYKODE THERAPEUTICS	Technik-/Wissenschafts-/F&E-Leiter	01.06.2021	01.06.2024
Symphogen A/S Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark.	Technik-/Wissenschafts-/F&E-Leiter	-	-

University of Copenhagen

Doctorate Degree

International

Dänemark	3
Norwegen	2

Operativ

Chief Tech/Sci/R&D Officer	2
Doctorate Degree	1

Sektoral

Health Technology	3
Consumer Services	2

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	1
NYKODE THERAPEUTICS	Health Technology

Private Unternehmen	1
Symphogen A/S Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark.	Health Technology

Private Unternehmen

Health Technology